UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000008402
Receipt number R000009757
Scientific Title POC study of SO2 imaging endoscopy
Date of disclosure of the study information 2012/07/19
Last modified on 2016/10/03 09:49:39

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

POC study of SO2 imaging endoscopy

Acronym

SO2 imaging POC study

Scientific Title

POC study of SO2 imaging endoscopy

Scientific Title:Acronym

SO2 imaging POC study

Region

Japan


Condition

Condition

neoplastic lesion, early cancer or advanced cancer of esophagus, stomach, colon or rectum.
ulcerative colitis

Classification by specialty

Gastroenterology

Classification by malignancy

Malignancy

Genomic information

YES


Objectives

Narrative objectives1

Exploratory evaluation of SO2 imaging endoscopy

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Evaluation of endoscopic image, pathology, gene expression

Key secondary outcomes

Adverse events


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Diagnosis

Type of intervention

Device,equipment

Interventions/Control_1

SO2 imaging

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1)>= 20 years old.
2)ECOG performance status of <= 2.
3)Written informed consent.
4)Meet the following criterion A , B or C.
A)endoscopic evaluation is scheduled for neoplastic lesion of esophagus, stomach, colon or rectum.
B)EMR or ESD is scheduled for early stage cancer of esophagus, stomach, colon or rectum.
C)surgery, chemotherapy or radiation is scheduled for advanced cancer of the target organ.
D)diagnosed as ulcerative colitis

Key exclusion criteria

1)Impossible to temporary discontinue anticoagulant or antiplatelet medication.
2)Women during pregnancy or breast-feeding.
3)Psychosis.
4)Ileus, obstruction or perforation of the digestive tract has been diagnosed or is suspected.
5)Active bacterial or fungal infection.
6)History of myocardial infarction or unstable angina pectoris within three months.
7)Uncontrollable hypertension.

Target sample size

31


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Kazuhiro Kaneko

Organization

National Cancer Center Hospital East

Division name

Gastrointestinal Oncology Division

Zip code


Address

6-5-1, Kashiwanoha, Kashiwa, Chiba, 277-8577, Japan

TEL

04-7133-1111

Email

kkaneko@east.ncc.go.jp


Public contact

Name of contact person

1st name
Middle name
Last name Yasuhiro Ohno

Organization

National Cancer Center Hospital East

Division name

Gastrointestinal Oncology Division

Zip code


Address

6-5-1, Kashiwanoha, Kashiwa, Chiba, 277-8577, Japan

TEL

04-7133-1111

Homepage URL


Email

yohno@east.ncc.go.jp


Sponsor or person

Institute

National Cancer Center Hospital East

Institute

Department

Personal name



Funding Source

Organization

Accelerating regulatory science initiative

Organization

Division

Category of Funding Organization

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor

FUJIFILM Corporation

Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

国立がん研究センター東病院(千葉県)


Other administrative information

Date of disclosure of the study information

2012 Year 07 Month 19 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2012 Year 04 Month 26 Day

Date of IRB


Anticipated trial start date

2012 Year 07 Month 01 Day

Last follow-up date

2015 Year 04 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2012 Year 07 Month 11 Day

Last modified on

2016 Year 10 Month 03 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000009757


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name